- Home
- DBL vs LFCR Comparison
DBL vs LFCR Comparison
Compare DBL & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBL
- LFCR
- Stock Information
- Founded
- DBL 2011
- LFCR 1986
- Country
- DBL United States
- LFCR United States
- Employees
- DBL N/A
- LFCR N/A
- Industry
- DBL
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- DBL
- LFCR Health Care
- Exchange
- DBL Nasdaq
- LFCR Nasdaq
- Market Cap
- DBL 292.0M
- LFCR 255.1M
- IPO Year
- DBL N/A
- LFCR N/A
- Fundamental
- Price
- DBL $15.42
- LFCR $6.63
- Analyst Decision
- DBL
- LFCR Buy
- Analyst Count
- DBL 0
- LFCR 4
- Target Price
- DBL N/A
- LFCR $8.00
- AVG Volume (30 Days)
- DBL 61.0K
- LFCR 145.9K
- Earning Date
- DBL 01-01-0001
- LFCR 11-06-2025
- Dividend Yield
- DBL 8.67%
- LFCR N/A
- EPS Growth
- DBL N/A
- LFCR N/A
- EPS
- DBL N/A
- LFCR N/A
- Revenue
- DBL N/A
- LFCR $128,867,000.00
- Revenue This Year
- DBL N/A
- LFCR $4.72
- Revenue Next Year
- DBL N/A
- LFCR $10.97
- P/E Ratio
- DBL N/A
- LFCR N/A
- Revenue Growth
- DBL N/A
- LFCR 0.47
- 52 Week Low
- DBL $13.75
- LFCR $4.76
- 52 Week High
- DBL $15.70
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- DBL 45.83
- LFCR 40.94
- Support Level
- DBL $15.28
- LFCR $6.67
- Resistance Level
- DBL $15.56
- LFCR $7.24
- Average True Range (ATR)
- DBL 0.17
- LFCR 0.25
- MACD
- DBL -0.02
- LFCR 0.01
- Stochastic Oscillator
- DBL 27.45
- LFCR 12.64
About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.